Showing 20 of 10290 recruiting trials
Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC
👨⚕️ Changyi Quan, MD, Tianjin Medical University Second Hospital📍 1 site📅 Started Jul 2025View details ↗
Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
👨⚕️ Yue He, M.D., the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jul 2025View details ↗
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
CUE-102 in Recurrent Glioblastoma
Study of BHV-1400 in IgA Nephropathy
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 45 sites📅 Started Jul 2025View details ↗
6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)
👨⚕️ Gerard Vockley, MD, PhD, UPMC Children's Hospital of Pittsburgh📍 1 site📅 Started Jul 2025View details ↗
Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →